AceLink Therapeutics Receives Orphan Drug Designation for its Novel GCS Inhibitor AL01211 for the Treatment of Fabry Disease Read more
ixlayer Partners with Curavit to Enable Convenient Patient Medical Testing Services for Decentralized Clinical Trials Read more
NaNotics to Collaborate with Mass General Cancer Center (MGCC) on Novel Nanomedicine for Treating Cancer Read more
Kite’s CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL) Read more
Bertis Announces Proteomic Based Research Results of New Biomarker for Ovarian Cancer Diagnosis Read more
Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes Read more
CARsgen Releases the First Clinical Batch of CAR T Cells from its RTP GMP Manufacturing Facility in North Carolina Read more